共 50 条
- [41] Safety of IL-23 p19 Inhibitors for the Treatment of Patients With Moderate-to-Severe Plaque Psoriasis: A Narrative Review Advances in Therapy, 2023, 40 : 3410 - 3433
- [43] Treatment with IL-17 Inhibitors Is Associated with Reduced eGFR in Patients with Psoriasis or Psoriatic Arthritis: A Retrospective Cohort Study JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 733 - 733
- [48] Authors’ reply to Borg and Thoning: “Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study” American Journal of Clinical Dermatology, 2021, 22 : 903 - 904